D
clinical programs for myotonic dystrophy type 1 DM1
Duchenne muscular dystrophy DMD
Associate Director, CMC Biologics
Comp not disclosed
2 shown for "C JavaScript TypeScript and Power Platform tools"
Summary
Dyne Therapeutics is a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases. They have a broad pipeline for serious muscle diseases, including clinical programs for myotonic dystrophy type 1 (DM1) and ...
D
clinical-stage muscle disease company
advancing innovative life-transforming therapeutics
Associate Director, Biostatistics
Comp not disclosed
Summary
Dyne Therapeutics is a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases. The company has a broad pipeline for serious muscle diseases, including clinical programs for myotonic dystrophy type 1 (DM1...
Ready to start?